
NeoGenomics NEO
€ 10.45
0.0%
Quartalsbericht 2025-Q2
hinzugefügt 29.07.2025
NeoGenomics P/E 2011-2025 | NEO
P/E Jährlich NeoGenomics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -19.4 | -20.9 | -13.6 | -308 | 1.33 K | 417 | 537 | -728 | -109 | -163 | 190 | 102 | 1.97 K | -63.9 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.97 K | -728 | 222 |
P/E anderer Aktien in der Diagnostik & Forschung
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
-37.1 | $ 19.27 | -0.08 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 21.36 | 0.47 % | $ 230 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
-0.988 | $ 0.23 | -6.02 % | $ 6.75 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 39.63 | -1.15 % | $ 1.1 B | ||
|
BioNano Genomics
BNGO
|
-0.0317 | $ 1.52 | -0.33 % | $ 1.93 M | ||
|
DarioHealth Corp.
DRIO
|
-0.73 | $ 10.02 | -0.2 % | $ 284 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
90.1 | $ 67.48 | 0.09 % | $ 26 B | ||
|
Danaher Corporation
DHR
|
39 | $ 229.66 | -0.59 % | $ 168 B | ||
|
Exact Sciences Corporation
EXAS
|
-10.8 | $ 101.57 | 0.03 % | $ 18.8 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 26.67 | -1.26 % | $ 806 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-2.74 | $ 19.41 | -1.62 % | $ 1.04 B | ||
|
Celcuity
CELC
|
-3.57 | $ 102.54 | -0.07 % | $ 4.05 B | ||
|
Anixa Biosciences
ANIX
|
-0.00564 | $ 3.21 | -6.14 % | $ 102 K | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
26 | $ 225.99 | 0.02 % | $ 41 B | ||
|
Guardant Health
GH
|
-13.4 | $ 103.56 | 1.15 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Illumina
ILMN
|
-13.4 | $ 134.96 | -0.27 % | $ 21.5 B | ||
|
Charles River Laboratories International
CRL
|
385 | $ 203.02 | -0.43 % | $ 10.4 B | ||
|
Myriad Genetics
MYGN
|
-7.64 | $ 6.43 | -1.83 % | $ 583 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.191 | $ 5.0 | -1.96 % | $ 2.68 M | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 7.1 | -0.63 % | $ 1.54 B | ||
|
National Research Corporation
NRC
|
32.6 | $ 18.52 | -0.67 % | $ 454 M | ||
|
Quest Diagnostics Incorporated
DGX
|
21.9 | $ 175.97 | 0.05 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
-2.14 | $ 6.64 | -2.71 % | $ 861 M | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
28.3 | $ 253.41 | -0.34 % | $ 21.3 B | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 182.07 | -0.88 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
42.4 | $ 687.73 | -0.07 % | $ 56.7 B | ||
|
Lantheus Holdings
LNTH
|
20.7 | $ 66.28 | -0.6 % | $ 4.59 B | ||
|
Mettler-Toledo International
MTD
|
34.6 | $ 1 415.66 | -0.17 % | $ 30 B | ||
|
Agilent Technologies
A
|
34.7 | $ 138.07 | -0.14 % | $ 42 B | ||
|
Pacific Biosciences of California
PACB
|
-4.61 | $ 1.78 | -5.12 % | $ 451 M | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.7 | 1.89 % | $ 6.2 M | ||
|
Bioventus
BVS
|
-2.25 | $ 7.36 | -0.27 % | $ 461 M |